Search company, investor...

Subchondral Solutions

subchondralsolutions.com

About Subchondral Solutions

Subchondral Solutions develops S-Core, a minimally-invasive approach to reconstruct fractures and joint damage.

Headquarters Location

7146 Edinger Ave Suite A

Huntington Beach, California, 92647,

United States

888-410-5622

Missing: Subchondral Solutions's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Subchondral Solutions's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Subchondral Solutions

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Subchondral Solutions is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

11,693 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Subchondral Solutions Patents

Subchondral Solutions has filed 9 patents.

The 3 most popular patent topics include:

  • Skeletal disorders
  • Arthritis
  • Conditions of the mucous membranes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/3/2020

4/12/2022

Orthopedic surgical procedures, Joints, Skeletal system, Arthritis, Bones of the head and neck

Grant

Application Date

4/3/2020

Grant Date

4/12/2022

Title

Related Topics

Orthopedic surgical procedures, Joints, Skeletal system, Arthritis, Bones of the head and neck

Status

Grant

Latest Subchondral Solutions News

Subchondral Solutions receives FDA 510(k) clearance for implant to treat bone edema

Sep 10, 2022

Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio Subchondral Solutions Inc. has announced FDA 501(k) clearance for its S-Core implant platform, according to a press release. The S-Core implant is indicated for the treatment of bone edema in the subchondral bone, according to the release. The implant, which is coated with hydroxyapatite to maximize bone and biologic healing, can also be used as a suture anchor and attachment for soft tissue allografts. Source: Adobe Stock “The recent clearance, with expanded indications, will allow Subchondral Solutions to broaden our marketing efforts and messaging,” Thomas Kinder, CEO of Subchondral Solutions, said in the release. “Our S-Core device provides surgeons in foot and ankle, upper extremities and sports medicine unparalleled options to best serve their patients,” Kinder added. “The S-Core implant platform may be used as a standalone screw for the fixation of trabecular fractures, fusion and osteotomies,” Jordan Peana, vice president of sales at Subchondral Solutions, said in the release. “The S-Core implant system may also be used with our S-Fibre suture when a suture anchor is needed for the attachment of soft tissue to bone.” Read more about

Subchondral Solutions Frequently Asked Questions (FAQ)

  • Where is Subchondral Solutions's headquarters?

    Subchondral Solutions's headquarters is located at 7146 Edinger Ave, Huntington Beach.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.